BIOGEN INC (BIIB)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BIIB
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BIIB | Clinical Professor of Medicine at UCSF | 77 | ["Executive Leadership and Business Operations","Drug Development","Healthcare and Pharma Leadership","Finance and Accounting","Public Board Service","Government and Public Policy","Medicine and Scientific Research"] | ["Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NBIX | Director | 77 | [] | ["Science and Medical Technology"] | 2026 |
| ANIP | Chairman of the Board and Co-Founder of Ceregene, Inc. and Clinical Professor of Medicine at the University of California, San Francisco | 63 | ["Chairman of the Board and Co-Founder of Ceregene, Inc.","Clinical Professor of Medicine at the University of California, San Francisco"] | [] | 2012 |
Biography sourced from the proxy statement filing.
Stephen A. Sherwin, M.D., Clinical Professor of Medicine at UCSF Director since 2010 Age 77 Board Committee Audit Key Skills Executive Leadership and Business Operations Drug Development Healthcare and Pharma Leadership Finance and Accounting Public Board Service Government and Public Policy Medicine and Scientific Research Relevant Expertise Dr. Sherwin has extensive knowledge of the life sciences industry through his advisory work in life sciences, and patient care and teaching in his specialty of medical oncology, as well as founding and leading life sciences companies. Dr. Sherwin s more than 30 years of industry experience significantly enhances Board oversight and development of Biogen s strategy and execution. Career Highlights Clinical Professor of Medicine at the University of California, San Francisco (since 2010) Volunteer Attending Physician in Hematology-Oncology at the Zuckerberg San Francisco General Hospital (since 2010) Advisory partner, Third Rock Ventures, LLC (since 2016) Chairman and Co-founder, Ceregene, a life sciences company acquired by Sangamo Biosciences (2001 2013) Chairman and Co-founder, Abgenix, Inc, an antibody company acquired by Amgen (1996 2006) CEO and Chairman, Cell Genesys, Inc., a life sciences company merged with BioSante Pharmaceuticals, Inc. (now ANI Pharmaceuticals, Inc.) (1994 2009) Other Public Company Boards Current Neurocrine Biosciences Inc. (since 1999) Innovent Biologics, Inc. (since 2025) Prior Epiphany Technology Acquisition Corp. (2022 2023) Bios Special Acquisition Corporation (2021 2023) Aduro Biotech, Inc (2015 2020) Education B.A. in Biology from Yale University M.D. from Harvard Medical School